Sign in

NCT01984762Recruiting

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus. Randomised Controlled Trial

Source: ClinicalTrials.gov · Last updated 25 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Obesity is a growing epidemic throughout the world and is followed by increasing incidence of type 2 diabetes that accounts for 90-95% of all cases of diabetes. Weight loss is a major objective, although difficult to achieve with medical treatments. Many recent studies demonstrated that bariatric surgery has the potency to achieve marked and sustained weight loss, and is also associated with a significant improvement in control of type 2 diabetes. The principal aim of this study is to compare two types of bariatric procedures, the Roux-en-Y gastric bypass (RYGBP) and sleeve gastrectomy (SG). The study hypothesis is that these procedures have equal efficacy with regard to resolution of type 2 diabetes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
134 (estimated)
First submitted
29 Oct 2013
Start date
Sept 2012
Primary completion date
1 Oct 2025
Lead sponsor
Göteborg University
NCT number
NCT01984762

What you commit to

  • Study type: Interventional
  • Planned participants: 134
  • From Sept 2012 to the primary completion date, 1 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Redo operations after previous bariatric procedures.

Other illness

  • Severe ongoing psychiatric disorder, alcoholism and substance abuse.
  • Type 1 diabetes or other non-type 2 forms of diabetes
  • End stage renal disease, retinopathy, neuropathy

Who the study is looking for

  • Type 2 diabetes mellitus
  • BMI between 35 and 50kg/m2.
  • Males and females
  • Age between 18 and 60 years.

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Sahlgrenska University Hospital
Coordinator of this site? Confirm its status
GothenburgSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.